SREBF2 and cancer: As cancer cells require high levels of cholesterol, elevated LDL uptake is often seen in cancers, as well as upregulation of LDLR, NPC1, SREBP-2, and the enzymes involved in the mevalonate pathway, resulting in an increased amount of cholesterol in the cells [10, 26].